GlobeNewswire by notified

OKTOBER MÆNGDER: FRAGT 1% LAVERE, PASSAGERER 4% HØJERE

Del
INVESTOR NEWS nr. 38 - 15. november 2023

Færge – fragt: De samlede mængder i oktober 2023 var 1,4% lavere end i 2022.

Nordsømængderne var lige under 2022, da robuste mængder fra bilindustrien blev modgået af lavere mængder mellem primært Sverige og Storbritannien.

Middelhavsmængderne var lavere end i 2022 som følge af stagnerende efterspørgsel i både Europa og Tyrkiet.

På Den Engelske Kanal var mængderne højere end i 2022 drevet af ruterne på Dover Strædet. Østersømængderne var lavere end i 2022 på grund af et aftagende aktivitetsniveau, ikke mindst i den svenske byggesektor, og en fortsat negativ påvirkning fra krigen i Ukraine.

For de sidste tolv måneder 2023-22 var der en nedgang i de samlede transporterede fragt-lanemeter på 9,9% til 38,6 mio. fra 42,8 mio. i 2022-21.

Færge - passager: Antallet af passagerer steg 4,0% som følge af flere passagerer på hovedsageligt Den Engelske Kanal. Antallet af biler steg 1,6%.

Det samlede antal passagerer steg 29% til 4,5 mio. for de sidste tolv måneder 2023-22 steg fra 3,5 mio. i 2022-21.


DFDS færgemængder
OktoberSidste tolv måneder
Fragt202120222023Ændr.2021-202022-212023-22Ændr.
Lanemeter, '0003.8253.4813.433-1,4%43.50842.78438.556-9,9%
Passager202120222023Ændr.2021-202022-212023-22Ændr.
Passagerer, '0001223303444,0%8243.4514.46929,5%


DFDS rapporterer månedlige færgemængder for fragt og passagerer med henblik på at give yderligere indsigt i trends for mængdeudviklingen i DFDS’ europæiske rutenetværk. DFDS’ færgeruter muliggør varehandel og rejser i og omkring Europa. Klik på link for at se et kort over det samlede netværk. Mængder for november 2023 forventes offentliggjort 12. december 2023 omkring kl. 10.00.

Kontakt

Torben Carlsen, CEO +45 33 42 32 01

Karina Deacon, CFO +45 33 42 33 42

Søren Brøndholt Nielsen, IR +45 33 42 33 59

Christina Bruun Madsen, Media +45 51 71 42 88


Om DFDS

Vi driver et transportnetværk i og omkring Europa med en omsætning på DKK 27 mia. og 13.000 heltidsansatte.

Vi transporterer varer i trailere med færge, vej og jernbane samt tilbyder komplementære og relaterede transport- og logistikløsninger.

Vi transporterer også passagerer i bil og til fods med færger på korte ruter og på ruter med overnatning.

DFDS blev grundlagt i 1866, har hovedkontor og er børsnoteret i København.


This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act.


Vedhæftet fil

For at se dette indhold fra www.globenewswire.com, så skal du give din accept på toppen af denne side.
For at se dette indhold fra ml-eu.globenewswire.com, så skal du give din accept på toppen af denne side.

Information om GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Følg pressemeddelelser fra GlobeNewswire by notified

Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.

Flere pressemeddelelser fra GlobeNewswire by notified

Hexagon Purus awarded purchase order by Ford Trucks to deliver a hydrogen fuel storage system for their prototype heavy-duty truck7.12.2023 08:07:00 CET | Press release

(Oslo, 7 December 2023) Hexagon Purus, a world leading supplier of zero-emission infrastructure and mobility solutions, has been awarded a purchase order by Ford Trucks to deliver a complete hydrogen fuel storage system for development of a Fuel Cell Electric-Powered Vehicle (FCEV) F-MAX as part of the Horizon Europe project ZEFES (Zero Emission Freight EcoSystem), a zero-emission logistics deployment project in which Ford Trucks participates with the vision of pioneering future transportation solutions. As a partner in project ZEFES, a pan-European project specifically targeting decarbonization of long-haul heavy-duty trucking in Europe, Ford Trucks will develop and deliver a fuel cell electric heavy-duty prototype F-MAX truck that will operate as part of a larger fleet of zero-emission trucks collecting data from real-world operations. The F-MAX FCEV will be Ford Trucks’ first fuel cell-powered vehicle, developed and manufactured in Turkey, and will begin European Ten-T corridor demo

AB Akola Group: notification on disposal of voting rights7.12.2023 08:04:58 CET | Press release

AB Akola Group (former AB Linas Agro Group), ISIN code LT0000128092 (hereinafter - the Company), received notification from UAB „SB Asset Management“ on the disposal of voting rights due to the increase in the authorized capital of the Company (enclosed). Additional information: Mažvydas Šileika, CFO of AB Akola Group Mob. +370 619 19 403 E-mail m.sileika@akolagroup.lt Attachment Notification-of-disposal-of-block-of-shares LNA 2023 12 06-s1206

Dividend Declaration7.12.2023 08:00:00 CET | Press release

Volta Finance Limited (VTA/VTAS) Dividend Declaration NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES Guernsey, 7 December 2023 Volta Finance Limited ("the Company") hereby announces that it has declared a quarterly interim dividend of €0.135 per share payable on 25 January 2024 amounting to approximately €4.94 million, approximately equating to an annualised 8.25% of net asset value. The ex-dividend date is 21 December 2023 with a record date of 22 December 2023. The Company has arranged for its shareholders to be able to elect to receive their dividends in either Euros or Pounds Sterling. Shareholders will, by default, receive their dividends in Euros, unless they have instructed the Company’s Registrar, Computershare Investor Services (Guernsey) Limited (“Computershare”), to pay dividends in Pounds Sterling. Such instructions may be given to Computershare either electronically via CREST or by using the Currency Election Form which has

Tag Systems and Fingerprint Cards AB (Fingerprints™) to bring biometric card to market7.12.2023 08:00:00 CET | Press release

Global card manufacturer Tag Systems (part of AUSTRIACARD Holdings AG) has achieved Mastercard certification for its biometric card based on Fingerprint Cards’ sensor and STMicroelectronics STPay-Topaz-Bio solution. Banks and fintechs can now issue Mastercard-branded biometric payment cards to enhance convenience and security for cardholders. Roger Carrico, Vice President, Head of Sales & Business development, Payment & Access at Fingerprints comments: “In Tag Systems we have a partner that likes to lead the way with high-end payment services. Banks and fintechs can take advantage of the opportunity to differentiate, retain and acquire customers and drive revenues.” Jon Neeraas, CEO at Tag Systems adds: “With this certification, we are excited to support our partners in issuing top-of-wallet biometric cards that utilize Fingerprints and ST latest technologies. Together, we are creating convenient, hygienic, and secure transactions for all purchases.” Following a partnership agreement i

MC2 Therapeutics Announces Completion of Enrollment in MC2-25 Ph2 Chronic Kidney Disease-associated Pruritus Trial7.12.2023 08:00:00 CET | Press release

MC2 Therapeutics Announces Completion of Enrollment in MC2-25 Ph2 Chronic Kidney Disease-associated Pruritus Trial MC2-25 CKD is a first-in-class drug candidate and a potential breakthrough in the understanding and treatment of urea associated skin diseases that has puzzled scientists for decadesMC2-25 CKD uses a di-peptide as an iso-cyanate scavenger to inhibit carbamylation of amino acids and proteins in the skinMC2-25 CKD has the potential to become the world’s first approved treatment for pre-dialysis Chronic Kidney Disease-associated Pruritus (CKD-aP), a debilitating condition thought to affect a significant proportion of the ~800 million people globally who suffer from Chronic Kidney Disease (CKD)111 patients enrolled in the multi-center trial across Europe with topline results expected in Q2 2024 Copenhagen, December 7th, 2023 – MC2 Therapeutics, a commercial stage biotech company focused on developing novel treatment paradigms within immune-mediated and inflammatory conditions,